TickerFactsScreenerDevelopers

Aldeyra Therapeutics, Inc. (ALDX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$19.22M2018: -$29.86M2019: -$44.98M2020: -$37.49M2021: -$42.56M2022: -$56.64M2023: -$30.33M2024: -$43.21M2025: -$33.35M-$33.35M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$33.35M+22.8%
2024-$43.21M-42.5%
2023-$30.33M+46.5%
2022-$56.64M-33.1%
2021-$42.56M-13.5%
2020-$37.49M+16.7%
2019-$44.98M-50.7%
2018-$29.86M-55.3%
2017-$19.22M—